JAMA Network
About The Study: This study showed venous thromboembolism (VTE) risk variation across hormonal contraceptives with highest rates for combined pills, especially those containing third-generation progestins, and no significant difference in risk for intrauterine devices (IUDs) relative to no use. For patches and implants, the increased VTE risk was uncertain due to limited data. Variation in VTE risk across products underscores the importance of personalized contraceptive counseling.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
